42 North Dental Says VideaAI Delivering a Clear and Measurable Impact on Treatment


DSO announces that its use of VideaHealth’s dental AI technology is helping its practices with diagnosis and treatment acceptance.

42 North Dental Says VideaAI Delivering a Clear and Measurable Impact on Treatment | Image Credit: © VideaHealth

42 North Dental Says VideaAI Delivering a Clear and Measurable Impact on Treatment | Image Credit: © VideaHealth

There has been plenty of buzz around AI-enabled technologies used in dentistry, and now comes word that a large dental support organization (DSO) is reporting great results as well as strong patient awareness and requests to receive care from practices using the innovative technology.

42 North Dental, the largest DSO in the Northeast, announced this week that its use of VideaHealth’s dental AI technology has had a “clear, measurable impact on clinical treatment for every practice using VideaAI.” The groups’ supported practices treat hundreds of thousands of patients per year across 100+ locations, and patient data shows that 90% of those who received diagnoses backed by VideaAI want to only receive care at practices that leverage VideaHealth’s artificial intelligence (AI), according to 42 North Dental.

When implemented, AI-enabled technologies can be a game changer not only for how dental professionals diagnose patients, but it can also help simplify and improve workflows for clinicians and staff.

“We recognized that dental AI has the potential to transform dentistry itself, and VideaHealth is the clear leader—offering the best product and partnership in the market,” Michael Scialabba, DDS, chief clinical officer at 42 North Dental, states in a press release. “VideaHealth’s dental AI, through early disease detection, helps improve patient lives and achieve better clinical outcomes by providing earlier and more minimally invasive care. 42 North Dental is committed to a culture of quality, safety, and efficiency, and VideaHealth’s dental AI helps us achieve these goals with every patient interaction.”

The DSO’s clinical evaluation process is described as stringent and continuous, with dentists from all geographies and specialties setting the clinical standards that practices strive to meet and choosing the best solutions to adhere to them. Clinicians across the 42 North Dental practices are currently diagnosing early-stage decay and disease at 2 times the rate prior to integrating VideaAI, and reportedly seeing the rate of treatment acceptance increase from 30% to 90%.

Florian Hillen, CEO and founder of VideaHealth, adds in the press release: “42 North Dental’s commitment to delivering the best dental care to all patients, in every situation, starts at the top and permeates the whole organization. Their decision to deploy VideaAI is a testament to their vision. Better care is always the goal, and clinicians aided by AI truly drive better outcomes.”

VideaHealth’s FDA-cleared dental AI technology is clinically proven to improve diagnostic accuracy and treatment plans, enabling dentists to consistently deliver better patient care. Videa Caries Assist is a caries detection algorithm powered by AI, featuring a unique and diverse coalition of data. This AI algorithm catches caries early, and trials done by the FDA indicate that the number of missed caries was 43% lower for dentists using the AI. This algorithm is based on the Videa Factory, a data set with more than 100 million data points from a variety of dental sources such as practices, DSOs, and insurance companies.

Related Videos
Video Test Drive: Primescan Connect from Dentsply Sirona
AHDA23 Annual Conference in 4 Minutes
Mastermind - Episode 28 - How Artificial Intelligence is Changing Dentistry
Dental Product Insights: Midmark® Extraoral Imaging System (EOIS)
Dental Product Insights: Videa Assist from VideaHealth
Roland DGA DWX-42W open-architecture chairside mill in action
5Ws* Video -Asiga MAX UV
Therapy in 3 Minutes - Technology: Making it Visible
Dental Product Insights: Digital X-ray Set-Up Best Practices
© 2023 MJH Life Sciences

All rights reserved.